Novavax Inc. jumped in early trading after US regulators fully approved its Covid vaccine, easing investors’ concerns after ...

Novavax shares surged more than 17% before the bell on Monday, following the long-delayed approval of its COVID-19 vaccine ...

The U.S. Food and Drug Administration approved Novavax's COVIDd-19 vaccine with age restrictions after a six-week delay.

This vaccine did previously have emergency approval by the FDA for use but can now be marketed in the U.S. for use, the ...

China on Sunday announced anti-dumping duties as high as 74.9% on imports of POM copolymers, a type of engineering plastic, ...

Commissioner Marty Makary suggested last week that the agency could update its vaccine approval guidelines “in the coming ...

The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine but with unusual ...

Singapore, Hong Kong, China, and Thailand are witnessing a spike in Covid-19 cases. In Singapore, the surge in infections is driven by LF.7 and NB.1.8 — both descendants of JN.1 variant, which is a ...

JN.1 may not be more severe, but it spreads fast, and that’s reason enough to stay alert. Across Asia, the priority is clear: ...

The U.S. Food and Drug Administration approved Novavax’s Covid-19 vaccine, but limited its use to older adults and people over the age of 12 with conditions that put them at risk due to the illness.

Covid shots are facing greater scrutiny from top federal health officials like RFK Jr. and the FDA's Marty Makary.